| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | ACS OMEGA (Q2) | ||
| Dergi ISSN | 2470-1343 Dergi Bilgileri (2024) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 10-2024 |
| Cilt / Sayı / Sayfa | 9 / 42 / 42905–42914 | DOI | 10.1021/acsomega.4c05619 |
| Makale Linki | https://doi.org/10.1021/acsomega.4c05619 | ||
| UAK Araştırma Alanları |
Tıbbi Biyokimya
|
||
| Özet |
| Inhibition ofaldose reductase (AR), α-glycosidase (α-GLY), and α-amylase (α-AMY) are some of the essential targets in diabetes mellitus (DM). Here, a series of imidazo[1,2-a]pyridine-based 1,3,4-thiadiazole derivatives (8a–k) were successfully synthesized and characterized using 1H NMR, 13C NMR, and HRMS spectroscopic techniques. The inhibition effects of the synthesized derivatives against AR, α-GLY, and α-AMY were evaluated using both in vitro and in silico methods. In vitro studies revealed that the derivatives (8a–k) showed significant inhibition activity. The results showed that the novel derivatives (8a–k) demonstrated potential inhibitory activity, with KI values covering the following ranges: 23.47 ± 2.40 to 139.60 ± 13.33 nM for AR and 6.09 ± 0.37 to 119.80 ± 12.31 μM for α-GLY, with IC50 values 81.14 to 153.51 μM for α-AMY. Furthermore, many of these compounds exhibited high inhibition activity … |
| Anahtar Kelimeler |
| Atıf Sayıları | |
| Web of Science | 27 |
| Google Scholar | 31 |
| Dergi Adı | ACS Omega |
| Kısa Adı | ACS OMEGA |
| Yayıncı | AMER CHEMICAL SOC |
| Açık Erişim | Evet |
| ISSN | 2470-1343 |
| E-ISSN | 2470-1343 |
| Wos Quartile | Q2 |
| Scopus Quartile | Q1 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | CHEMISTRY, MULTIDISCIPLINARY |
| Scopus Kategoriler | CHEMICAL ENGINEERING (MISCELLANEOUS) | CHEMISTRY (MISCELLANEOUS) |